Mirador Therapeutics Names Gregg Gilbert As CFO
Mirador Therapeutics has appointed Gregg Gilbert as CFO. With over 25 years of experience in biopharma equity research and investment banking, Gilbert will bring extensive leadership expertise to the role.
Mirador Therapeutics Inc., a leading precision medicine company specialising in cutting-edge therapeutics for immunology and inflammation, has announced the appointment of Gregg Gilbert as Chief Financial Officer.
With over 25 years of experience in biopharma equity research analysis and investment banking, Gilbert brings a wealth of leadership expertise to his new role.
